Life-Line

Quick links to important sections

Life-Line

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Life-Line

Quick Facts

Property Description
Active ingredient Docusate (typically as a salt like Sodium)
Form Capsule, Tablet, Oral Solution, Enema, Suppository
Pharmacological class Emollient Laxative (Stool Softener)
Common Use Easing passage of hard, dry stool
Origin Synthetic Compound (Surfactant)

What Type of Medicine is Life-Line?

The medicine Life-Line is the commercial designation for the active pharmaceutical ingredient Docusate, which is formally classified as an emollient laxative, a category commonly known as a stool softener. The pharmacological class of Docusate is that of a surface-active agent or anionic surfactant, meaning its action is chemically related to reducing interfacial tension. This medicine is utilized as an option when straining during defecation must be avoided, such as in postoperative patients. This distinction highlights that the medication operates to alter the physical properties of the fecal mass rather than directly stimulating the bowel musculature. Life-Line is generally available as an over-the-counter (OTC) product.

Composition, Forms, and Its General Therapeutic Purpose

The core component of the drug is Docusate, which is typically presented as a salt, such as Docusate Sodium, although Docusate Calcium and Docusate Potassium variations exist. As a synthetic structure, Docusate functions by reducing the surface tension of the fecal mass, which facilitates the incorporation of water and lipids into the dry stool. This action leads to the primary general therapeutic purpose of the medicine: the softening of the fecal mass to ease the discomfort and strain associated with hard, dry stool. Its utility is derived from this wetting action. Docusate is prepared for both oral and rectal administration in various fundamental dosage forms, including capsules (softgels), tablets, syrups, oral solutions, and enemas.

Regulatory References

  1. NICE: Management of constipation
  2. NIH StatPearls

What side effects are possible with Life-Line?

Possible Side Effects and Safety Information

The safety profile for Life-Line (Docusate) is derived from official regulatory documentation and establishes a framework for potential adverse reactions and use restrictions. The most frequently documented adverse events are typically confined to the gastrointestinal system.


Adverse Reaction Classifications

Classification Examples of Reactions
Common (up to 1 in 10) Abdominal cramps, Diarrhea
Uncommon (up to 1 in 100) Nausea, Rash
Frequency Not Known Anaphylactic reaction, Severe diarrhea, Rectal irritation

The safety data categorizes the potential effects across system-organ classes, including Gastrointestinal disorders and Immune system disorders. Events such as diarrhea are often noted as an indication of overuse or use extending beyond the short-term duration recommended in the regulatory label.


Serious Safety Considerations and Restrictions

Serious adverse reactions, though rare, include life-threatening hypersensitivity reactions such as anaphylaxis, as well as consequences of severe diarrhea that could lead to fluid and electrolyte imbalances.

Regulatory documents impose specific restrictions on the use of this medicine. It must not be administered when symptoms such as undiagnosed acute abdominal pain, nausea, or vomiting are present, or in cases of known intestinal obstruction. Additionally, co-administration with mineral oil is restricted due to the potential for increased systemic absorption of the oil. The label also notes specific caution for long-term use in individuals with pre-existing hepatic impairment.

Overdose and Emergency Response

Overdose and when to seek help

This information reflects the documented overdose profile as defined by authoritative government regulatory agencies (e.g., FDA, EMA). It is not clinical advice and should not replace emergency medical assessment.

Documented Overdose Manifestations

The official labeling specifies that acute overexposure may result in distinct clinical signs. These manifestations often involve central nervous system depression, potentially progressing to coma, and significant cardiovascular instability. Documented physiological effects include severe hypotension and characteristic changes on the electrocardiogram (e.g., QRS widening).

Life-Threatening Outcomes

Serious complications cited in regulatory documents include respiratory arrest, severe ventricular arrhythmias, and ultimately, circulatory collapse. Patients with pre-existing cardiac conduction abnormalities or liver impairment are noted to be at increased risk for these severe outcomes following overdose.

Emergency Action Mandated by Regulatory Labeling

Urgent medical attention must be sought immediately following known or suspected overdose, regardless of the current presence of symptoms.

Regulatory instructions require immediately initiating supportive measures and administering the specified pharmacological antidote, where applicable, followed by continuous patient observation. Management typically includes protocols for limiting further absorption, ensuring airway patency, and continuous cardiac monitoring.

Therapeutic Uses of Life-Line

Life-Line provides targeted symptomatic relief and is applied in addressing symptoms related to physical discomfort. Stool softeners are commonly used to soften stools and make them easier to pass, providing a functional benefit in managing specific symptoms and conditions.

It is used for managing occasional constipation and irregularity characterized by the hardness and dryness of the fecal mass. The medicine is relevant for easing symptoms that interfere with daily functioning, such as difficult defecation, straining avoidance, and supportive care during anorectal conditions.

The medication is commonly used in clinical settings that involve acute or disruptive symptom patterns where minimizing physical straining during defecation is considered relevant. This supports patient groups, including those with heart conditions or anorectal problems, in situations requiring short-term symptomatic assistance where exertion is considered relevant to manage. The supportive benefit contributes to easing distress during symptomatic periods and helps ease the overall symptom burden.

“It assists with maintaining functional stability when symptoms create noticeable physiological strain.”

Quick Fact: Relief for Hard Stools
Symptom Targeted Hard, dry stools difficult to pass
Primary Benefit Softening the fecal mass
Use Context Straining avoidance (e.g., post-surgery, cardiac patients)

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Life-Line (Linezolid) is an antibiotic approved for treating infections caused by certain Gram-positive bacteria, including various forms of pneumonia and complicated or uncomplicated skin and skin structure infections (SSSIs). It is also indicated for infections caused by Vancomycin-resistant Enterococcus faecium (VRE).

However, Life-Line is not indicated for infections caused by Gram-negative bacteria or for the treatment of catheter-related bloodstream infections.


Contraindications and Cautions

Certain conditions and drug interactions prohibit the use of Life-Line or require careful patient monitoring:

  • Absolute Contraindications: Life-Line should not be used in patients with a known hypersensitivity to the drug or any of its components. It is also strictly contraindicated in patients currently taking monoamine oxidase inhibitors (MAOIs) or within two weeks of discontinuing an MAOI, due to the risk of severe drug interactions, including Serotonin Syndrome and elevated blood pressure.
  • Pre-existing Conditions: Caution is necessary in patients with underlying myelosuppression (including anemia or thrombocytopenia), severe kidney or liver impairment, uncontrolled hypertension, pheochromocytoma, or a history of seizures or diabetes.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction profile of Life-Line (Docusate) as detailed in government regulatory information, focusing on required restrictions and interaction categories.


Official Interaction Statements

The most significant and strictly enforced interaction relates to substances that may have enhanced systemic absorption when co-administered with this medicine.

  • Formal Contraindication: The co-administration of oral Docusate and oral Mineral Oil is formally prohibited/contraindicated in regulatory labeling. Docusate's action as a surfactant is documented to increase the gastrointestinal absorption and systemic exposure of Mineral Oil.
  • Pharmacodynamic Interaction: Concurrent use of Life-Line with other laxative products carries a documented risk of additive gastrointestinal effects due to combined pharmacodynamic action.
  • Herbal Products: Some authoritative regulatory synthesis notes indicate that the non-drug product Licorice is generally not recommended for co-use.

Regulatory Summary of Constraints

The regulatory profile is defined by the prohibition of a single combination (oral Mineral Oil) resulting from its effect on exposure. Official documentation does not typically include explicit warnings regarding metabolic (CYP-enzyme) or drug-transporter-mediated interactions, nor does it specify any mandatory timing separation requirements for administration.

Mechanism of Action

How Life-Line Works: Mechanism of Action

Life-Line's action is defined by its role as an allosteric inhibitor of the enzyme mTOR, specifically within the mTOR Complex 1 (mTORC1). This interaction occurs when the molecule binds to a regulatory site on the protein, stabilizing an inactive conformation of the kinase. The resulting inhibition halts the phosphorylation of key downstream substrates (e.g., S6K and 4E-BP1), effectively dampening proliferative signaling that drives rapid cell division and protein synthesis.

This molecular cascade leads to a significant shift in cellular metabolism, moving the internal environment away from high-speed growth (anabolism) toward recycling (catabolism). By removing the inhibitory control of mTORC1 over autophagy, Life-Line permits the cell to enhance its internal maintenance and clearance processes. This regulation of cellular energetics establishes a physiological effect characterized by cellular stasis and a modified allocation of metabolic resources.

The pathway modulation is subject to biological feedback loops (e.g., PI3K/Akt pathway) that attempt to restore proliferative signaling. The drug's sustained inhibitory effect results in a net reduction in overall growth signals, leading to an altered pattern of cellular activity at the systemic level.

Dosage and Administration Information

How to Use Life-Line

The usage of Life-Line (Docusate) is strictly defined by regulatory guidelines for the short-term management of occasional constipation. These instructions specify the approved administration routes, standard dosing ranges, and mandatory conditions for proper use.

Approved Administration and Dosing

Life-Line is officially approved for both oral and rectal administration, depending on the dosage form. Oral forms include capsules, tablets, and liquids, while the rectal form is typically an enema.

Administration Route Standard Adult Daily Dose (Ages ge 12 years) Key Administration Rule
Oral (Capsules/Tablets) 100 mg to 300 mg (in single or divided doses) Must be taken with a full glass of water
Rectal (Enema) One unit daily (e.g., 283 mg) For rectal use only; not to be taken by mouth

Frequency and Duration

Oral doses may be taken as a single daily dose or split into divided doses, not exceeding the maximum daily limit specified on the product label. The onset of action for the oral route typically occurs within 12 to 72 hours, while the rectal enema acts much faster, usually within 2 to 15 minutes.

Crucially, Life-Line is authorized for short-term use only. It must not be used for more than 7 days unless specifically directed by a healthcare professional.

Population-Specific Instructions

Dosage guidelines vary by age group as specified in official labeling:

  • Children 2 to under 12 years: The authorized dose is generally 50 mg to 100 mg daily.
  • Children under 2 years: Use and dosage must be determined by a healthcare provider.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Life-Line

Research has been conducted on Life-Line (Docusate) focusing on its use in various clinical research contexts. The following summary describes the types of research conducted, the outcomes measured in those studies, and the aspects that remain uncertain, drawing only from officially recognized scientific literature and regulatory data.


Evidence for Use in Occasional and Chronic Constipation

The research explored Docusate in occasional and chronic constipation through short-term randomized controlled trials (RCTs), systematic reviews, and meta-analyses. Research examined outcomes related to physical discomfort, such as changes in stool consistency (often using the Bristol Stool Form Scale) and the number of weekly bowel movements. Study populations included adults with idiopathic constipation, as well as groups of older adults.

Findings describe patterns observed during the study periods, but results have been mixed. Comprehensive reviews have frequently noted that findings were mixed; many RCTs reported no significant differences when Docusate was compared directly against placebo in terms of increasing bowel movement frequency.


Evidence in Supportive Care and Straining Avoidance

Docusate was evaluated in research exploring supportive care contexts, a research scenario involving situations where minimizing physiological strain or stress during defecation is a question. Research examined the combination of Docusate with a stimulant laxative as part of a regimen. Trials described contradictory findings regarding any potential added contribution from Docusate when compared to the stimulant laxative used alone.

What remains uncertain is the specific, isolated contribution of Docusate. Comparative evidence is lacking to explore how Docusate was associated with outcomes related to preventing straining in high-risk groups, such as those with cardiac conditions. The available data describe group patterns observed within combination therapy settings.


Study Durations and Findings on Long-Term Use

The majority of clinical research involving Life-Line has been confined to short-term study designs, typically observing responses over defined time intervals that last only a few weeks (often 10 to 26 days). These follow-up durations were limited, focusing on episodic or acute changes in symptoms. There is limited information for long-term outcomes or how the observed short-term patterns might translate into sustained stability. Long-term effects are not fully established.

Key Studies & References

  1. Docusate (StatPearls - NCBI Bookshelf)
  2. Docusate Drug Information (MedlinePlus)
  3. Management of Chronic Constipation in Adults: A Systematic Review and Meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Life-Line (FAQ)


Q: How quickly does Life-Line start making a difference?

The time it takes for Life-Line to start working depends on how it is administered. According to official product information, the softening effect from oral forms (capsules/tablets) usually begins within 12 to 72 hours. Rectal forms, such as enemas, act much faster, typically taking effect within 2 to 15 minutes.

Q: Can you take Life-Line with pain relievers like Tylenol (acetaminophen)?

Regulatory labels specifically contraindicate co-administration with mineral oil and warn against using other laxatives. However, official regulatory profiles do not typically list explicit warnings or restrictions for common over-the-counter pain relievers, such as acetaminophen (Tylenol).

Q: What is the longest someone usually stays on Life-Line?

Official labeling states that this medicine is for short-term use only. Use should generally not exceed 7 consecutive days unless a healthcare professional has specifically directed otherwise. This duration is to manage occasional constipation.

Q: Can Life-Line interact with herbal supplements?

The interaction profile mainly focuses on prohibiting the use of mineral oil and warning about other laxatives. Some authoritative documents note that the non-drug product Licorice is generally not recommended for co-use. Information regarding the use of specific herbal supplements should be reviewed by a healthcare provider.

Q: Is Life-Line safe to take if I have liver problems?

Regulatory documentation advises that specific caution should be exercised when this medicine is administered to individuals with pre-existing hepatic impairment (liver problems). This caution is particularly emphasized in situations involving use over a prolonged period.

Q: Does Life-Line interact with alcohol, and what kind of reaction can happen?

Official regulatory documentation lists known drug and food interactions for this medicine. Generally, these documents do not contain explicit warnings or contraindications regarding co-consumption with alcohol.

Q: Is Life-Line something that needs to be tapered off?

Because this medicine is intended for short-term use only, typically not exceeding 7 days, there are usually no formal instructions in official labeling requiring that the medicine be gradually tapered off upon cessation.

Q: Does Life-Line affect your ability to drive or operate machinery?

The official adverse reaction profile does not typically list central nervous system effects like dizziness or drowsiness. The most common side effects are localized to the digestive system (e.g., abdominal cramps and diarrhea).

Q: What kinds of medical conditions prevent someone from taking Life-Line?

Regulatory documents prohibit the use of this medicine when certain acute symptoms are present, including undiagnosed acute abdominal pain, nausea, or vomiting. It is also restricted in cases of known intestinal obstruction. Caution is advised for use in individuals with pre-existing hepatic (liver) impairment.

Q: Are there any specific blood tests required before or during treatment with Life-Line?

Official regulatory labeling for this medicine does not typically specify mandatory blood tests or routine laboratory monitoring before or while the medicine is being used.

Q: What happens if I miss a dose of Life-Line?

Standard instructions typically suggest that if a dose is missed, the next dose is taken at the next regularly scheduled time. The maximum daily dosage specified on the product label should not be exceeded.

Q: Is it common to feel tired or dizzy when taking Life-Line?

Official safety data lists common side effects, which are primarily related to the digestive tract (e.g., abdominal cramps and diarrhea). Fatigue or dizziness are generally not listed as common or uncommon adverse reactions in the standard regulatory labeling.

Q: What should I do if the side effects of Life-Line are really bothering me?

Patient information commonly states that if side effects become severe or persistent, discontinuing use is typically advised. If signs of a serious allergic reaction occur, seeking immediate medical attention is recommended.

Q: Is Life-Line safe for older adults (seniors)?

Regulatory labels authorize use for adults, generally defined as ages 12 years and older, according to standard dosing. However, caution is often recommended when treating the elderly population due to the potential for existing health issues or the concurrent use of multiple medications.

Q: What are the signs that Life-Line is actually working?

As a stool softener, the medicine’s purpose is to ease the passage of hard, dry stool. Signs that it is performing its intended function include the production of softer, moister stool and a reduction in straining during defecation.

Q: Is Life-Line safe for people with high blood pressure?

Official labeling does not typically list high blood pressure as a direct contraindication for this medicine. However, general caution related to maintaining proper fluid and electrolyte balance is often advised with laxative use, as severe imbalance could potentially affect blood pressure.

Q: Why do some people say they felt worse when they first started Life-Line?

The official label notes that common effects are gastrointestinal, such as abdominal cramping and diarrhea. These expected digestive disturbances, which are related to the action of the medicine, may be temporarily perceived as worsening symptoms when treatment is initiated.

Q: How does Life-Line affect the body compared to placebo in studies?

Regulatory reviews of clinical research often note that findings comparing this medicine to an inactive placebo have been mixed. Many trials have reported no statistically significant differences in the primary outcome of increasing bowel movement frequency.

Q: What's the difference between Life-Line and a vitamin supplement?

Life-Line is formally classified as an emollient laxative, meaning it is a regulated drug (active pharmaceutical ingredient) intended to treat a medical condition (constipation). Vitamin supplements, in contrast, are regulated as dietary supplements.

Q: Does Life-Line have a risk of dependence or withdrawal?

Official labeling strongly warns against long-term use. This caution is based on the risk that prolonged use may result in the body developing a reliance on laxatives to maintain regular bowel function. This is related to the drug class, not a formal withdrawal syndrome.

Q: Are there any long-term effects of taking Life-Line for many years?

Official documentation states the medicine is for short-term use only. The majority of research evidence is limited to short-term studies, and the long-term effects of taking the medicine for prolonged periods are not fully established.

Q: Where can I find summaries of the clinical trials for Life-Line?

Summaries of clinical trials and regulatory reviews can be accessed in the official drug labels, such as those provided by the FDA, and on government-run clinical trial registries like ClinicalTrials.gov.

Q: What percentage of people experience the major side effects listed for Life-Line?

The frequency of side effects is categorized in the official safety data. For example, some common effects are listed as occurring in up to 1 in 10 users, and uncommon effects in up to 1 in 100 users.

Q: Do I need to take Life-Line with food?

The administration rule for oral forms specifies that the medicine must be taken with a full glass of water to ensure proper action. There is generally no mandatory requirement listed in official documents to take it with food.

Q: What does the research say about Life-Line's effectiveness over time?

Clinical research evidence for this medicine is confined to short-term study designs, typically lasting only a few weeks. Information regarding its sustained effectiveness or stability over periods longer than the short-term study duration is limited.

Q: How does Life-Line target the specific illness it treats?

Life-Line (Docusate) is classified as a surface-active agent, or surfactant. It works by reducing the surface tension of the fecal mass, which facilitates the incorporation of water and lipids into the stool, thereby softening the fecal mass to ease passage.

Q: What happens if I accidentally take two doses of Life-Line close together?

Regulatory information indicates caution regarding exceeding the maximum daily dose. Overuse or overdosage is associated with symptoms like severe diarrhea and potential fluid and electrolyte imbalances.

Q: Are there any known drug interactions between Life-Line and common cold medicines?

Official regulatory labels specifically warn against mineral oil and other laxatives. There are generally no explicit, universal warnings listed regarding interactions with common, over-the-counter cold and flu medicines.

Q: Is it normal for Life-Line to take a few weeks to reach its full effect?

No. The onset of action for oral forms is expected to occur within 12 to 72 hours (up to 3 days), not several weeks. If there is no bowel movement within this timeframe, official instructions often suggest seeking guidance from a healthcare provider.

Q: Can Life-Line be crushed or split if it's a tablet?

Regulatory guidance specifies approved administration methods for different dosage forms. Unless the medicine is explicitly stated to have a score line, or is specifically labeled as a chewable or liquid, it is typically intended to be swallowed whole.

How should Life-Line be stored and disposed of?

How to Store and Dispose of Life-Line (Docusate Sodium)

Life-Line must be stored strictly according to the conditions defined in the official regulatory labeling to maintain product stability and integrity.

Storage Requirement Official Condition
Temperature Store at Controlled Room Temperature, typically 15 C to 30 C (59 F to 86 F).
Protection Protect the medicine from freezing and moisture.
Container Keep in the closed container and ensure it is tightly closed.
Child Safety Keep this medicine out of the reach and sight of children.

Disposal Instructions

Unused or expired Life-Line must be disposed of according to official guidelines, such as utilizing a drug take-back program. The medicine must not be flushed down the toilet or poured into a drain, and disposal should align with local and national regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Life-Line found in:

A-Z Index: